486 results
Page 2 of 25
8-K
EX-10.1
a6cc6
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
8-K
8gz o0tk24
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
8-K
vukozu
29 Jun 22
Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors
5:17pm
425
EX-99.1
4dmhssskky1lbuogtk
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
uzkn6l04ly dbzxta6j
21 Jun 22
Regulation FD Disclosure
6:19am
425
afmjsztwy 8074zar1wh
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-10.1
048e0iix1bjvcg
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.2
f9kb dgi5so
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
23vy2d7 0sn3yzgrz
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.2
mjhjl9r
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.2
26djeqe
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm